The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice

Alcoholism: Clinical and Experimental Research

Volumn 34, Issue 12, 2010, Pages 2053-2060

  Kamens, Helen M ^a   Andersen, Jimena ^a   Picciotto, Marina R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ataxia; Ethanol; Nicotinic Acetylcholine Receptors; Sedation; Varenicline

Indexed keywords

ALCOHOL; NICOTINIC AGENT; PARTIAL AGONIST; VARENICLINE;

ACUTE DRUG ADMINISTRATION; ACUTE TOXICITY; ALCOHOL INTOXICATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; BALANCE BEAM TEST; C57BL 6 MOUSE; CONTROLLED STUDY; DOWEL TEST; DRUG MECHANISM; FEMALE; FUNCTION TEST; HYPNOSIS; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RIGHTING REFLEX; ROTAROD TEST; SEDATION;

ANIMALS; ATAXIA; BENZAZEPINES; DRUG EVALUATION, PRECLINICAL; DRUG PARTIAL AGONISM; DRUG SYNERGISM; ETHANOL; FEMALE; HYPNOTICS AND SEDATIVES; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NICOTINIC AGONISTS; QUINOXALINES; REFLEX, RIGHTING;

ANIMALIA; MUS;

EID: 78649596142     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01301.x     Document Type: Article

References (49)

1. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Cogliano V (2007) Carcinogenicity of alcoholic beverages. Lancet Oncol 8:292-293.
2. Bergstrom HC, Palmer AA, Wood RD, Burkhart-Kasch S, McKinnon CS, Phillips TJ (2003) Reverse selection for differential response to the locomotor stimulant effects of ethanol provides evidence for pleiotropic genetic influence on locomotor response to other drugs of abuse. Alcohol Clin Exp Res 27:1535-1547.
3. Blednov YA, Harris RA (2008) Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions. Int J Neuropsychopharmacol 11:775-793.
4. Boehm SL II, Peden L, Jennings AW, Kojima N, Harris RA, Blednov YA (2004) Over-expression of the fyn-kinase gene reduces hypnotic sensitivity to ethanol in mice. Neurosci Lett 372:6-11.
5. Bowers BJ, McClure-Begley TD, Keller JJ, Paylor R, Collins AC, Wehner JM (2005) Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol. Alcohol Clin Exp Res 29:295-302.
6. Cahill K, Stead LF, Lancaster T (2008) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev (3):CD006103.
7. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y, Mansbach RS, Chambers LK, Rovetti CC, Schulz DW, Tingley FD III, O'Neill BT (2005) Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48:3474-3477.
8. Collins AC, Romm E, Selvaag S, Turner S, Marks MJ (1993) A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice. J Pharmacol Exp Ther 266:1390-1397.
9. Corrao G, Bagnardi V, Zambon A, La Vecchia C (2004) A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38:613-619.
10. Corrao G, Rubbiati L, Zambon A, Arico S (2002) Alcohol-attributable and alcohol-preventable mortality in Italy. A balance in 1983 and 1996. Eur J Public Health 12:214-223.
11. Crabbe JC, Cotnam CJ, Cameron AJ, Schlumbohm JP, Rhodes JS, Metten P, Wahlsten D (2003a) Strain differences in three measures of ethanol intoxication in mice: the screen, dowel and grip strength tests. Genes Brain Behav 2:201-213.
12. Crabbe JC, Metten P, Cameron AJ, Wahlsten D (2005) An analysis of the genetics of alcohol intoxication in inbred mice. Neurosci Biobehav Rev 28:785-802.
13. Crabbe JC, Metten P, Ponomarev I, Prescott CA, Wahlsten D (2006) Effects of genetic and procedural variation on measurement of alcohol sensitivity in mouse inbred strains. Behav Genet 36:536-552.
14. Crabbe JC, Metten P, Yu CH, Schlumbohm JP, Cameron AJ, Wahlsten D (2003b) Genotypic differences in ethanol sensitivity in two tests of motor incoordination. J Appl Physiol 95:1338-1351.
15. Dani JA, Harris RA (2005) Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci 8:1465-1470.
16. Dudek BC, Yi DK, Gilliam DM, Irtenkauf KT (1993) Comparisons of subcolonies of selectively bred long-sleep and short-sleep mice. Behav Genet 23:245-250.
17. Elliott BM, Faraday MM, Phillips JM, Grunberg NE (2005) Adolescent and adult female rats differ in sensitivity to nicotine's activity effects. Pharmacol Biochem Behav 80:567-575.
18. Ericson M, Lof E, Stomberg R, Soderpalm B (2009) The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system. J Pharmacol Exp Ther 329:225-230.
19. De Fiebre NC, Dawson R Jr, De Fiebre CM (2002) The selectively bred high alcohol sensitivity (HAS) and low alcohol sensitivity (LAS) rats differ in sensitivity to nicotine. Alcohol Clin Exp Res 26:765-772.
20. De Fiebre CM, Romm E, Collins JT, Draski LJ, Deitrich RA, Collins AC (1991) Responses to cholinergic agonists of rats selectively bred for differential sensitivity to ethanol. Alcohol Clin Exp Res 15:270-276.
21. Harwood H (1998) Updating Estimates of the Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods, and Data. National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Service, NIH Publication No. 98-4327. Rockville, MD.
22. Kamens HM, Andersen J, Picciotto MR (2010) Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice. Psychopharmacology (Berl) 208:613-626.
23. Kamens HM, Phillips TJ, Holstein SE, Crabbe JC (2005) Characterization of the parallel rod floor apparatus to test motor incoordination in mice. Genes Brain Behav 4:253-266.
24. Kendler KS, Myers J, Prescott CA (2007) Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch Gen Psychiatry 64:1313-1320.
25. King AC, Volpicelli JR, Frazer A, O'Brien CP (1997) Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology (Berl) 129:15-22.
26. Larsson A, Engel JA (2004) Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci Biobehav Rev 27:713-720.
27. Li TK, Volkow ND, Baler RD, Egli M (2007) The biological bases of nicotine and alcohol co-addiction. Biol Psychiatry 61:1-3.
28. Linsenbardt DN, Moore EM, Gross CD, Goldfarb KJ, Blackman LC, Boehm SL II (2009) Sensitivity and tolerance to the hypnotic and ataxic effects of ethanol in adolescent and adult C57BL/6J and DBA/2J mice. Alcohol Clin Exp Res 33:464-476.
29. Madden PA, Bucholz KK, Martin NG, Heath AC (2000) Smoking and the genetic contribution to alcohol-dependence risk. Alcohol Res Health 24:209-214.
30. Madden PA, Heath AC (2002) Shared genetic vulnerability in alcohol and cigarette use and dependence. Alcohol Clin Exp Res 26:1919-1921.
31. Marks MJ, Romm E, Campbell SM, Collins AC (1989) Variation of nicotinic binding sites among inbred strains. Pharmacol Biochem Behav 33:679-689.
32. McCaul ME, Wand GS, Eissenberg T, Rohde CA, Cheskin LJ (2000) Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology 22:480-492.
33. McClearn GE, Kitahama K (1981) Selective breeding for ethanol sensitivity: short-sleep and long-sleep mice, In Development of Animal Models as Pharmacogenetic Tools (McClearn GE, Deitrich RA, Erwin VG eds), pp 147-159. USDHHS/NIAAA, Rockville, MD.
34. McKee SA, Harrison EL, O'Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, Picciotto MR, Petrakis IL, Estevez N, Balchunas E (2009) Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry 66:185-190.
35. Mihalak KB, Carroll FI, Luetje CW (2006) Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70:801-805.
36. Picciotto MR (2003) Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci 24:493-499.
37. Ponomarev I, Crabbe JC (2002) A novel method to assess initial sensitivity and acute functional tolerance to hypnotic effects of ethanol. J Pharmacol Exp Ther 302:257-263.
38. Rehm J, Gmel G, Sempos CT, Trevisan M (2003) Alcohol-related morbidity and mortality. Alcohol Res Health 27:39-51.
39. Reus VI, Obach RS, Coe JW, Faessel H, Rollema H, Watsky E, Reeves K (2007) Varenicline: new treatment with efficacy in smoking cessation. Drugs Today (Barc) 43:65-75.
40. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD III, Williams KE (2007a) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985-994.
41. Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE (2007b) Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci 28:316-325.
42. Rollema H, Hajos M, Seymour PA, Kozak R, Majchrzak MJ, Guanowsky V, Horner WE, Chapin DS, Hoffmann WE, Johnson DE, McLean S, Freeman J, Williams KE (2009) Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. Biochem Pharmacol 78:813-824.
43. Schiff ER (1997) Hepatitis C and alcohol. Hepatology 26:39S-42S.
44. Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE (2007) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A 104:12518-12523.
45. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H (1994) Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151:1463-1467.
46. Talcott GW, Poston WS II, Haddock CK (1998) Co-occurrent use of cigarettes, alcohol, and caffeine in a retired military population. Mil Med 163:133-138.
47. Taslim N, Al-Rejaie S, Saeed Dar M (2008) Attenuation of ethanol-induced ataxia by alpha(4)beta(2) nicotinic acetylcholine receptor subtype in mouse cerebellum: a functional interaction. Neuroscience 157:204-213.
48. Tritto T, McCallum SE, Waddle SA, Hutton SR, Paylor R, Collins AC, Marks MJ (2004) Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. Nicotine Tob Res 6:145-158.
49. Zaniewska M, McCreary AC, Stefanski R, Przegalinski E, Filip M (2008) Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats. Synapse 62:935-939.